New-onset diabetes after transplantation in tacrolimus-treated, living kidney transplantation: long-term impact and utility of the pre-transplant OGTT

@inproceedings{Iida2010NewonsetDA,
  title={New-onset diabetes after transplantation in tacrolimus-treated, living kidney transplantation: long-term impact and utility of the pre-transplant OGTT},
  author={Shoichi Iida and Hideki Ishida and Tadahiko Tokumoto and Kazuya Omoto and Hiroki Shirakawa and Tomokazu Shimizu and Hiroyuki Amano and Kiyoshi Setoguchi and Taiji Nozaki and Daisuke Toki and Daisuke Tokita and Kazunari Tanabe},
  booktitle={International Urology and Nephrology},
  year={2010}
}
To evaluate the role of the oral glucose tolerance test (OGTT) before transplantation and to examine the risk factors for new-onset diabetes after transplantation (NODAT) during long-term follow-up of renal transplant recipients receiving FK-based therapy. The study evaluated 378 patients pre-transplantation using the OGTT and assigned them to one of three groups: Group 1, normal pattern; Group 2, impaired fasting glucose (IFG)/impaired glucose tolerance (IGT) pattern (IFG/IGT); and Group 3, DM… CONTINUE READING